Webinar

The Agile Trial: A New Clinical Leadership

Interested in reading more about how agile and decentralized approaches actually offer sponsors more centralized command and…

Blog

Breaking Through Mistrust to Better Mental Health in Black Communities

Reflecting upon Science 37’s “Mental Health & Clinical Trials in the Black Community” webinar (presented with George Floyd…

Report

How Agile Clinical Trials are Impacting CNS Research

We know that clinical research is undergoing transformation across the board—but how will it impact…

Blog

Powering Rare Disease Research with Agile, Decentralized and Patient-Centric Approaches

The increased adoption of more agile, decentralized, and more patient-centric approaches is a very welcome…

Blog

Reshaping Clinical Trials in 2022

Author: Darcy Forman, Chief Delivery Officer, Science 37 The world is ready – and able…

Blog

Privacy By Design Protects Clinical Trial Participants

Author: Jen Davis, JD, MBA, MA, CIPP/E, CIPP/USDeputy General Counsel and Privacy Officer, Science 37…

Blog

How Access to the HPV Vaccination is Helping to Eliminate Cervical Cancer

With the arrival of Cervical Health Awareness Month, comes news out of the U.K. that the human…

Blog

Working with Native Americans to Navigate the COVID-19 Crisis

This Native American Heritage Month, we strive to raise awareness on how we can help…

Case Study

Enrolling 55% of Total Participants for a Phase 3 Neurology Trial

Science 37 was the top enrolling site, enrolling 55% of total study participants and achieving…

Case Study

Delivering 28% of Total Enrollment for a Phase 3 Respiratory Trial

Science 37 was the top enrolling site, contributing 28% of total enrolled patients over a…

Case Study

Delivering 25% of Total Enrollment for a Phase 3 Rare Disease Trial

Science 37 was the top enrolling site, contributing 25% of all randomized patients nationwide. Through…

Case Study

Enrolling 49% of Total Participants Across 49 States for an Oncology Trial

Science 37 was the top enrolling site, delivering 49% of total study enrollment and outperforming…